Takeda To Supply Anemia Drug To Major U.S. Dialysis Center Operator
02:29 EDT 13 Jul 2012 | Elsevier Business Intelligence
Takeda Pharmaceutical has agreed to supply its Omontys (peginesatide) drug used in kidney dialysis to Germany's Fresenius Medical Care, which operates more than 100 U.S. dialysis centers.
Original Article: Takeda To Supply Anemia Drug To Major U.S. Dialysis Center Operator
More From BioPortfolio on "Takeda To Supply Anemia Drug To Major U.S. Dialysis Center Operator"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
